Shoko Kawai

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Clinical Impact of Osimertinib Dose Reduction in the First-Line Setting on EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Retrospective Monocentric Study.

Clinical Impact of Osimertinib Dose Reduction in the First-Line Setting on EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Retrospective Monocentric Study.

Journal: OncoTargets and therapy

Published: September 13, 2024

Real-world Prognostic Data on Unresectable Stage III Non-small-cell Lung Cancer Treated with Concurrent Chemoradiation Therapy by Histological Type.

Real-world Prognostic Data on Unresectable Stage III Non-small-cell Lung Cancer Treated with Concurrent Chemoradiation Therapy by Histological Type.

Journal: Internal medicine (Tokyo, Japan)

Published: February 12, 2024

Intralobar pulmonary sequestration presenting as multiple nodular pulmonary lesions and focal emphysema.

Intralobar pulmonary sequestration presenting as multiple nodular pulmonary lesions and focal emphysema.

Journal: Respirology case reports

Published: November 17, 2023

Opioid-induced nausea and vomiting: a dexamethasone multicentre prospective study.

Opioid-induced nausea and vomiting: a dexamethasone multicentre prospective study.

Journal: BMJ supportive & palliative care

Published: April 06, 2022

Association between the baseline tumor size and outcomes of patients with non-small cell lung cancer treated with first-line immune checkpoint inhibitor monotherapy or in combination with chemotherapy.

Association between the baseline tumor size and outcomes of patients with non-small cell lung cancer treated with first-line immune checkpoint inhibitor monotherapy or in combination with chemotherapy.

Journal: Translational lung cancer research

Published: October 04, 2021

Correction to: An analysis of the radiological factors associated with respiratory failure in COVID-19 pneumonia and the CT features among different age categories.

Correction to: An analysis of the radiological factors associated with respiratory failure in COVID-19 pneumonia and the CT features among different age categories.

Journal: Japanese journal of radiology

Published: August 13, 2021

Number of Patients with Influenza and COVID-19 Coinfection in a Single Japanese Hospital during the First Wave.

Number of Patients with Influenza and COVID-19 Coinfection in a Single Japanese Hospital during the First Wave.

Journal: Japanese journal of infectious diseases

Published: May 06, 2021

Premature phase II study of amrubicin as palliative chemotherapy for previously treated malignant pleural mesothelioma.

Premature phase II study of amrubicin as palliative chemotherapy for previously treated malignant pleural mesothelioma.

Journal: Thoracic cancer

Published: January 02, 2021

An analysis of the radiological factors associated with respiratory failure in COVID-19 pneumonia and the CT features among different age categories.

An analysis of the radiological factors associated with respiratory failure in COVID-19 pneumonia and the CT features among different age categories.

Journal: Japanese journal of radiology

Published: December 30, 2020

A case series on the safety of immunotherapy with reduced blood testing frequency in lung cancer patients.

A case series on the safety of immunotherapy with reduced blood testing frequency in lung cancer patients.

Journal: International journal of clinical oncology

Published: October 26, 2020

Durvalumab Consolidation Treatment after Chemoradiotherapy for an HIV-Positive Patient with Locally Advanced Non-Small Cell Lung Cancer.

Durvalumab Consolidation Treatment after Chemoradiotherapy for an HIV-Positive Patient with Locally Advanced Non-Small Cell Lung Cancer.

Journal: Case reports in oncology

Published: March 21, 2020

A randomized phase III study comparing continuation and discontinuation of PD-1 pathway inhibitors for patients with advanced non-small-cell lung cancer (JCOG1701, SAVE study).

A randomized phase III study comparing continuation and discontinuation of PD-1 pathway inhibitors for patients with advanced non-small-cell lung cancer (JCOG1701, SAVE study).

Journal: Japanese journal of clinical oncology

Published: February 27, 2020

Showing 1-12 of 20

Last Updated: 09/26/2026